Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will make an estimate of the projected net NHS spend on medicines (a) before and (b) after accounting for forecast rebates due via the (i) Voluntary Scheme for Branded Medicines Pricing, Access and Growth and (ii) Branded Health Service Medicines (costs) Regulations 2018 for the next five years.

Annex 3 of the document titled Annexes to the 2024 Voluntary Scheme for Branded Medicines Pricing, Access and Growth outlines the forecasts of measured sales and payments from branded medicines. This document is available at the following link:

https://assets.publishing.service.gov.uk/media/657b2993254aaa000d050de1/Annexes-2024-voluntary-scheme-for-branded-medicines-pricing-access-and-growth.pdf